Abstract
Lipid peroxidation (LPx) products were measured as thiobarbituric acid-reactive substances (TS) and lipid-soluble fluorescent pigments (FP) in both plasma and CSF from MS patients and controls. Although no significant changes were found in MS plasma, we report here for the first time increases in both TS and FP in MS CSF (p<0.05 and p<0.01, respectively, compared with patients with other neurological diseases), indicating that increased LPx in CNS may be a feature of MS. Levels of transferrin were normal but caeruloplasmin (CP), a major antioxidant plasma protein, was significantly raised in MS patients (p<0.01) and this may represent an adaptive response to increased oxidative challenge. Neither of these proteins was detectable in CSF using radial immunodiffusion. There was no significant correlation between the severity or duration of the disease nor the period since the last relapse and either LPx products of CP suggesting that the changes observed in this work are not simply the direct result of demyelination and tissue damage.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hunter, M. I. S., Lao, M. S., Burtles, S. S., andDavidson, D. L. W. 1984. Erythrocyte antioxidant enzymes in multiple sclerosis and the effect of hyperbaric oxygen. Neurochem. Res. 9:507–516.
Kurantsin-Mills, J., Samji, N., Moscarello, M. A., andBoggs, J. M. 1982. Comparison of membrane structure, osmotic fraglity and morphology of multiple sclerosis and normal erythrocytes. Neurochem. Res. 7:1523–1540.
Caspary, E. A., Sewell, F., andField, E. J. 1967. Red blood cell fragility in multiple sclerosis. Brit. Med. J. 2:610–611.
Schauf, C. L., Frischer, H., andDavis, F. A. 1980. Mechanical fragility of erythrocytes in multiple sclerosis. Neurology 30:323–325.
Shukla, V. K. S., Jensen, G. E., andClausen, J. 1977. Erythrocyte glutathione peroxidase deficiency in multiple sclerosis. Acta Neurol. Scand. 56:542–550.
Szeinberg, A., Golan, R., Ezzer, J. B., Sarova-Pinhas, I., andKindler, D. 1981. Decreased erythrocyte glutathione peroxidase activity in multiple sclerosis. Acta Neurol. Scand. 60:265–271.
Szeinberg, A., Golan, R., Ben-Ezzer, J., Sarova-Pinhas, I., andKindler, D. 1981. Glutathione peroxidase activity in various types of blood cell in multiple sclerosis. Acta Neurol. Scand. 63:67–75.
Jensen, G. E., Gissel-Neilsen, G., andClausen, J. 1980. Leukocyte glutathione peroxidase E.C.1.11.1.9 activity and selenium level in multiple sclerosis. J. Neurol. Sci. 48:61–68.
Jensen, G. E., andClausen, J. 1984. Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis. J. Neurol. Sci. 63:45–53.
Zachara, B., Gromadzinska, J., Czernicki, J., Maciejek, Z., andChmielewski, H. 1984. Red blood cell glutathione peroxidase activity in multiple sclerosis. Klin. Wochenschr. 62:179–182.
Polidoro, G., Di Ilio, C., Arduini, A., La Rovere, G., andFederici, G. 1984. Superoxide dismutase, reduced glutathione and thiobarbituric acid-reactive products in erythrocytes of patients with multiple sclerosis. Int. J. Biochem. 16:505–509.
Rogovina, N. I., andKoklov, A. P. 1980. Metabolism of lipid peroxidation products in multiple sclerosis patients. Zh. Nevropatol. Paikhiatr. Im. S. S. Korsakova 80:696–700.
Yu, R. K., Ueno, K., Glaser, G. H., andTourtellotte, W. W. 1982. Lipid and protein alterations of spinal cord and cord myelin of multiple sclerosis. J. Neurochem. 39:464–477.
Woelk, H., andBorri, P. 1973. Lipid and fatty acid composition of myelin purified from normal and MS brains. Eur. Neurol. 10:250–260.
Gopfert, E., Pytlik, S., andDebuch, H. 1980. 2′,3′-Cyclic nucelotide 3′-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains. J. Neurochem. 34:732–739.
Thompson, R. H. S. 1975. Unsaturated fatty acids in multiple sclerosis. Pages 184–191.In Davison, A. N., Humphrey, J. H., Liversedge, L. A., McDonald, W. I., andPorterfield, J. S. (eds). Multiple sclerosis research. HMSO: London.
Baker, R. W. R., Thompson, R. H. S., andZilkha, K. J. 1964. Serum fatty acids and multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 27:408–414.
Sanders, H., Thompson, R. H. S., Wright, H. P., andZilkha, K. J. 1968. Further studies on platelet adhesion and serum cholesteryl linoleate levels in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 31:321–325.
Neu, I. S. 1983. Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurol. Scand. 67:151–163.
Gul, S., Smith, A. D., Thompson, R. H. S., Wright, H. P., andZilkha, K. J. 1970. Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J. Neurol. Neurosurg. Psychiat. 33:506–510.
Cherayil, G. D. 1984. Sialic acid and fatty acid concentrations in lymphocytes, red blood cells and plasma from patients with multiple sclerosis. J. Neurol. Sci. 63:1–10.
Bernsohn, J., andStephanides, L. M. 1967. Aetiology of multiple sclerosis. Nature 215:821–823.
Dick, G. 1976. The aetiology of multiple sclerosis. Proc. Roy. Soc. Med. 69:611–615.
Jones, R., Preece, A. W., Luckman, N. P., andForrester, J. A. 1983. The analysis of the red blood cell unsaturated fatty acid test for multiple sclerosis using laser cytopherometry. Phys. Med. Biol. 28:1145–1151.
Mertin, J., andMeade, C. J. 1977. Relevance of fatty acids in multiple sclerosis. Brit. Med. Bull. 33:67–71.
Wickstrom, J., Westermark, T., andPalo, J. 1976. Selenium, vitamin E and copper in multiple sclerosis. Acta Neurol. Scand. 54:287–290.
Fletcher, B. L., Dillard, C. J., andTappel, A. L. 1973. Measurement of fluorescent lipid peroxidation products in biological systems and tissues. Anal. Biochem. 52:1–9.
Al-Timimi, D. J., andDormandy, T. L. 1977. The inhibition of lipid autoxidation by human caeruloplasmin. Biochem. J. 168:283–288.
Satoh, K. 1978. Serum lipid peroxide in cerebrovascular disorders detected by a new colorimetric method. Clin. Chim. Acta. 90:37–43.
Stocks, J., andDormandy, T. L. 1971. The autoxidation of human red cell lipids induced by hydrogen peroxide. Brit. J. Haematol. 20:95–111.
Dillard, C. J., andTappel, A. L. 1971. Fluorescent products of lipid peroxidation of mitochondria and microsomes. Lipids 6:715–721.
Beynon, R. J. 1983. In: Contributed Programs Vol. 1, Biochemistry Microcomputer Group, University of Liverpool.
Halliwell, B., andGutteridge, J. M. C. 1984. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet (i):1396–1397.
Slater, T. F. 1984. Free-radical mechanisms in tissue injury. Biochem. J. 222:1–15.
Gutteridge, J. M. C., andStocks, J. 1981. Caeruloplasmin: physiological and pathological perspectives. CRC Crit. Rev. Clin. Lab. Sci. 14:257–329.
Gutteridge, J. M. C., Richmond, R., andHalliwell, B. 1980. Oxygen free radicals and lipid peroxidation. Inhibition by the protein caeruloplasmin. FEBS Lett. 112:269–272.
Bowern, N., Ramshaw, I. A., Clark, I. A., andDoherty, P. C. 1984. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J. Exp. Med. 160:1532–1543.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hunter, M.I.S., Nlemadim, B.C. & Davidson, D.L.W. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res 10, 1645–1652 (1985). https://doi.org/10.1007/BF00988606
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00988606